Fungemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
Line 18: Line 18:
{{CMG}}
{{CMG}}


{{EH}}
 


==Overview==
==Overview==
Line 60: Line 60:


{{Intensive care medicine}}
{{Intensive care medicine}}
{{SIB}}
 


[[Category:Fungal diseases]]
[[Category:Fungal diseases]]

Revision as of 02:55, 9 August 2012

Fungemia
ICD-9 117.9
MeSH D016469

WikiDoc Resources for Fungemia

Articles

Most recent articles on Fungemia

Most cited articles on Fungemia

Review articles on Fungemia

Articles on Fungemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fungemia

Images of Fungemia

Photos of Fungemia

Podcasts & MP3s on Fungemia

Videos on Fungemia

Evidence Based Medicine

Cochrane Collaboration on Fungemia

Bandolier on Fungemia

TRIP on Fungemia

Clinical Trials

Ongoing Trials on Fungemia at Clinical Trials.gov

Trial results on Fungemia

Clinical Trials on Fungemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fungemia

NICE Guidance on Fungemia

NHS PRODIGY Guidance

FDA on Fungemia

CDC on Fungemia

Books

Books on Fungemia

News

Fungemia in the news

Be alerted to news on Fungemia

News trends on Fungemia

Commentary

Blogs on Fungemia

Definitions

Definitions of Fungemia

Patient Resources / Community

Patient resources on Fungemia

Discussion groups on Fungemia

Patient Handouts on Fungemia

Directions to Hospitals Treating Fungemia

Risk calculators and risk factors for Fungemia

Healthcare Provider Resources

Symptoms of Fungemia

Causes & Risk Factors for Fungemia

Diagnostic studies for Fungemia

Treatment of Fungemia

Continuing Medical Education (CME)

CME Programs on Fungemia

International

Fungemia en Espanol

Fungemia en Francais

Business

Fungemia in the Marketplace

Patents on Fungemia

Experimental / Informatics

List of terms related to Fungemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Fungemia (also known as Candidemia, Candedemia, and Invasive Candidiasis) is the presence of fungi or yeasts in the blood. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. Recently, it has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.

Risk factors

The two most important risk factors are:

  1. Use of broad-spectrum antibiotics
  2. Colonization by fungi (see e.g. candidiasis)

Other risk factors include:

Differential diagnosis of most common pathogens

The most commonly known pathogen is Candida albicans, causing roughly 70% of fungemias, followed by Candida glabrata with 10%, and Aspergillus with 1%. However, the frequency of infection by T. glabrata, Candida tropicalis, C. krusei, and C. parapsilosis is increasing, especially when significant use of fluconazole is common.

Signs and symptoms

Symptoms can range from mild to extreme, often described as extreme flu-like symptoms. Pain, mental disorders, chronic fatigue, infections, are a few of the long list of associated symptoms with Fungemia.

Diagnosis

The diagnosis is complicated, as routine blood cultures have poor sensitivity.

Treatment

Treatment involves use of antifungals, e.g. fluconazole or amphotericin.

See also

External link

Template:WS Template:WH